Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/02/2010US20100303760 Treatment and/or prevention of cancer and/or arthritis
12/02/2010US20100303759 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); treating cancer responsive to interferon alpha therapy
12/02/2010US20100303758 Novel Glucocorticoid Receptor Agonists
12/02/2010US20100303757 Methods of Treating Chronic Neurogenic Inflammation Using Interleukin Retargeted Endopepidases
12/02/2010US20100303756 Methods of Treating Urogenital-Neurological Disorders Using Interleukin Retargeted Endopepidases
12/02/2010US20100303755 Hepatitis C Virus Inhibitors
12/02/2010US20100303754 Process for preparation of cyclodextrin oligomers or polymers, products obtained and uses
12/02/2010US20100303744 Personal-care composition comprising oil-soluble solid sunscreens
12/02/2010US20100303723 Drug delivery systems using fc fragments
12/02/2010US20100303720 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49
12/02/2010US20100303719 Anti-cancer compounds
12/02/2010US20100303718 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials
12/02/2010US20100303717 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials Cross Reference to Related Applications
12/02/2010US20100303716 Switchable nano-vehicle delivery systems, and methods for making and using them
12/02/2010US20100301268 Multi-part substitution infusion fluids and matching anticoagulants
12/02/2010DE102007033359B4 Verwendung eines Granulins oder einer Granulin-ähnlichen Verbindung zur Therapie oder Prophylaxe von chronischen Schmerzen Use of a granulin or granulin-like compound for the treatment or prophylaxis of chronic pain
12/02/2010CA2763950A1 Use of 2 anti-sparc antibodies to predict response to chemotherapy
12/02/2010CA2763641A1 Expression of recombinant proteins
12/02/2010CA2763638A1 Iap inhibitors
12/02/2010CA2763614A1 Iap inhibitors
12/02/2010CA2763471A1 Combination therapy for the treatment of multiple myeloma
12/02/2010CA2763466A1 Fibromodulin peptide
12/02/2010CA2763446A1 Stem cell targeting
12/02/2010CA2763440A1 Assays for influenza virus hemagglutinins
12/02/2010CA2763439A1 Antigen-binding proteins
12/02/2010CA2763395A1 Novel peptides, process for preparation thereof, and use thereof
12/02/2010CA2763327A1 Inhibition 0f inflammation using antagonists of muc1
12/02/2010CA2763207A1 Cyclosporin derivatives for treating inflammatory diseases and conditions
12/02/2010CA2761904A1 Treatment of tissue adhesion
12/02/2010CA2761817A1 Production of glycoproteins
12/01/2010EP2256205A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256204A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256203A1 IL-23 and its receptor; related reagents and methods
12/01/2010EP2256202A2 Stimulus-inducible i (kappa)b kinase ikk signalsome
12/01/2010EP2256201A2 Modulation of eIF4E expression
12/01/2010EP2256200A2 Modulation of eIF4E expression
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256186A1 Myocardial grafts and cellular compositions
12/01/2010EP2256131A1 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
12/01/2010EP2256130A1 Novel insulin derivatives
12/01/2010EP2256129A1 Insulin derivatives
12/01/2010EP2255828A1 Methods of therapy for cancers expressing the CD40 antigen
12/01/2010EP2255825A2 Composition for preventing or treating brain diseases
12/01/2010EP2255824A1 Immunosuppression using Chaperonin 10
12/01/2010EP2255823A1 Intestinal immune system stimulator
12/01/2010EP2255798A2 Sphingosine-1-phosphate receptor agonists for use in the treatment of optic neuritis
12/01/2010EP2255787A1 Synthetic glycolipid-containing liposomes
12/01/2010EP2255674A1 Soybean protein material for patients with renal disease and foods made from the same
12/01/2010EP2254908A1 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
12/01/2010EP2254906A1 Protease stabilized, acylated insulin analogues
12/01/2010EP2254905A2 Protease-stabilized insulin analogues
12/01/2010EP2254904A2 Oligopeptidic compounds and uses thereof
12/01/2010EP2254597A2 Methods of treatment using anti-mif antibodies
12/01/2010EP2254591A2 Inhibition and treatment of gastrointestinal biofilms
12/01/2010EP2254589A1 Compounds and methods for the prevention or treatment of restenosis
12/01/2010EP2254588A2 Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
12/01/2010EP2254583A1 Anticancer agent
12/01/2010EP2254559A1 Composition for sustained release delivery of proteins or peptides
12/01/2010EP2254411A2 Complement inhibitors as therapeutic agents for treatment of cancer
12/01/2010EP2040689B1 Solution comprising n-acetylcysteine and gluconic acid, and methods to reduce, treat and/or prevent oxidative stress and cell activation
12/01/2010EP1869071B1 Tnf-alpha binding polypeptide, uses thereof and methods employing it
12/01/2010EP1806141B1 Par-2 antagonists
12/01/2010EP1765850B1 Substituted propane phosphinic acid derivatives
12/01/2010EP1725583B1 Methods for increasing protein polyethylene glycol (peg) conjugation
12/01/2010EP1713446B1 Ternary non-lamellar lipid compositions
12/01/2010EP1648922B1 Spatially-defined macrocyclic compounds useful for drug discovery
12/01/2010EP1583832B1 Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
12/01/2010EP1569679B1 Chaperonin 10 immunosuppression
12/01/2010EP1561807B1 Method of degrading hardly degradable protein
12/01/2010EP1425033B1 Use of hcg and lh in controlled ovarian hyperstimulation
12/01/2010EP1423425B1 Receptor, the use thereof, and mouse antibodies
12/01/2010EP1414996B1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
12/01/2010EP1399176B1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
12/01/2010EP1373301B1 Reducing the immunogenicity of fusion proteins
12/01/2010EP1284137B1 Nonoral preparation having three-layer structure
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1997352B Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
12/01/2010CN1939534B Externally-applied preparation containing human growth incretion or human granular leukocyte macrophage stimulus factor for treating injury ulceration
12/01/2010CN1913915B Methods for protecting against radiation using flagellin
12/01/2010CN1902307B Tissue regeneration method
12/01/2010CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN1617703B Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof
12/01/2010CN101903529A SM-protein based secretion engineering
12/01/2010CN101903400A Insulinotropic peptide synthesis using solid and solution phase combination techniques
12/01/2010CN101903399A Clostridial toxin netb
12/01/2010CN101903398A Edible product having an immunostimulating effect
12/01/2010CN101903050A Anisotropic implant and its method of production
12/01/2010CN101903039A Novel patient subgroups for thrombolysis
12/01/2010CN101903038A Thermostabilization of proteins
12/01/2010CN101903037A Method of administering conjugates
12/01/2010CN101903036A Active soluble post-translationally modified neuregulin isoforms
12/01/2010CN101903035A Methods of treating chronic neurogenic inflammation using modified clostridial toxins
12/01/2010CN101903030A Stabilized factor ix formulations containing trehalose
12/01/2010CN101903014A Solid lipid microcapsules containing growth hormone in the inner solid core
12/01/2010CN101903009A Topical compositions containing desthiobiotin and its derivatives and a method of treating skin
12/01/2010CN101899469A Shuttle plasmid and method for efficiently expressing cecropin and lysozyme genes
12/01/2010CN101899444A Full-length polynucleotide sequence for coding chicken II-type collagen and application thereof
12/01/2010CN101899443A Method for regulating and controlling FAF1 (Fas-associated Factor-1) genes, composition and application thereof
12/01/2010CN101899116A Non-invasive high-penetrability epidermal growth factor and application thereof
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 3163